SEC Filings | 4D pharma plc

Filing date	Form	Description	View
07 Jul 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-016315.pdf 0001493152-21-016315.rtf 0001493152-21-016315.xls
04 Jun 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-013623.pdf 0001493152-21-013623.rtf 0001493152-21-013623.xls
25 May 2021	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0001493152-21-012793.pdf 0001493152-21-012793.rtf 0001493152-21-012793.xls
25 May 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-012824.pdf 0001493152-21-012824.rtf 0001493152-21-012824.xls
25 May 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-012826.pdf 0001493152-21-012826.rtf 0001493152-21-012826.xls
24 May 2021	EFFECT	EFFECT	View HTML 9999999995-21-002082.pdf 9999999995-21-002082.rtf 9999999995-21-002082.xls
21 May 2021	CORRESP	CORRESP	View HTML 0001493152-21-012536.pdf 0001493152-21-012536.rtf 0001493152-21-012536.xls
21 May 2021	CORRESP	CORRESP	View HTML 0001493152-21-012532.pdf 0001493152-21-012532.rtf
30 Apr 2021	20-F/A	Amendment to a previously filed 20-F	View HTML 0001493152-21-010214.pdf 0001493152-21-010214.rtf 0001493152-21-010214.xls EX-101.INS - XBRL INSTANCE FILE
30 Apr 2021	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0001493152-21-010234.pdf 0001493152-21-010234.rtf 0001493152-21-010234.xls

Data provided by Kaleidoscope.